US Stock MarketDetailed Quotes

KOD Kodiak Sciences

Watchlist

3.060
+0.050+1.66%

Close Mar 27 16:00 ET

3.060
0.0000.00%

Post 20:01 ET

161.03MMarket Cap-0.84P/E (TTM)

Kodiak Sciences Stock Forum

Teddy123

1 hour ago

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

$Kodiak Sciences (KOD.US)$
Kodiak Sciences Cuts Losses by 26%, Advances Two Phase 3 Trials with $168M War Chest

Teddy123

Mar 11 13:25

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

$Kodiak Sciences (KOD.US)$
Clinical Trial Success: Kodiak Enrolls 250+ Patients for Novel Diabetic Eye Drug

Jsmooth420365

Dec 4, 2024 18:15

$Kodiak Sciences (KOD.US)$ riding 9 nicely 👌 looking for possible swing entry on pullback

George Soros II

Oct 18, 2024 23:07

$Kodiak Sciences (KOD.US)$

Meltyy

May 16, 2024 14:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Jaguar8

May 14, 2024 08:31

$Kodiak Sciences (KOD.US)$
NEWS
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

Jaguar8

May 3, 2024 04:39

$Kodiak Sciences (KOD.US)$
NEWS
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

JuliaBiswas

Feb 5, 2024 18:12

Who is the winner today, after the poditive data announced on 03 Feb
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$

JuliaBiswas

Feb 5, 2024 12:11

$Kodiak Sciences (KOD.US)$ announced first time results of KSI-501 ABC Phase 1 study. The data outlined safety and biocativity of KSI-501, along with high binding affinity and bioactivity against VEGF and IL-6.

Moomoo AI

Jan 26, 2024 19:03

While Kodiak Sciences' cash runway is reassuring, its cash burn relative to its market cap is concerning. The company's high expenditure relative to its market value suggests an elevated risk of funding distress, making the stock a risky investment.